This is not the most recent version of the article. View current version (3 JUN 2014)

Intervention Protocol

You have free access to this content

Anticoagulation therapy versus placebo for pulmonary hypertension

  1. Ifeanyi Ezedunukwe1,*,
  2. Hilary Enuh2,
  3. Jay Nfonoyim3,
  4. Collins U Enuh4

Editorial Group: Cochrane Airways Group

Published Online: 5 AUG 2013

DOI: 10.1002/14651858.CD010695


How to Cite

Ezedunukwe I, Enuh H, Nfonoyim J, Enuh CU. Anticoagulation therapy versus placebo for pulmonary hypertension (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD010695. DOI: 10.1002/14651858.CD010695.

Author Information

  1. 1

    Lagos University Teaching Hospital, Department of Medicine, Lagos, Nigeria

  2. 2

    Richmond University Medical Center, Department of Internal Medicine, New York, USA

  3. 3

    Richmond University Medical Center, Intensive Care Unit, New York, USA

  4. 4

    University of Abuja Teaching Hospital, Department of Anaesthesia, Abuja, Nigeria

*Ifeanyi Ezedunukwe, Department of Medicine, Lagos University Teaching Hospital, Lagos, Nigeria. ifeanyiezedunukwe@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 5 AUG 2013

SEARCH

This is not the most recent version of the article. View current version (03 JUN 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  1. To evaluate the effectiveness of and potential adverse events with the use of anticoagulation in the management of pulmonary hypertension (PH).
  2. To evaluate the effective therapeutic INR in pulmonary hypertensive patients receiving anticoagulants (North America 1.5 to 2.5, European centres 2.0 to 3.0).